News
Promising human Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
New CEPI-funded trial to launch in Kenya – the first ever Phase II trial of a Rift Valley fever vaccine in an endemic country Earlier vaccine studies show positive safety data, and generation of an immune response Rift Valley fever is a mosquito-borne disease affecting people and animals across Africa OSLO/NAIROBI, October 13 – A […]
Read More